NICE recommends routine access to beta interferon drug for MS
Multiple sclerosis patients to have routine access to beta interferon drug, says NICE in new draft guidance.
List view / Grid view
Multiple sclerosis patients to have routine access to beta interferon drug, says NICE in new draft guidance.
The findings from the two pivotal phase 3 trials pave the way for ozanimod to enter the New Drug Approval process with the FDA...